Add BrightSurf on Google Email

Conquering a severe complication of celiac disease

A team of researchers has identified IL-15 as a key player in the development of enteropathy-associated T cell lymphoma, a high-grade invasive lymphoma associated with severe celiac disease. Treatment with an antibody directed at IL-15 successfully wiped out intraepithelial lymphocytes in mice overexpressing human IL-15.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 3, 2010

Type 1 diabetes and celiac disease linked

Type 1 diabetes and celiac disease share common genetic mechanisms, including autoimmunity-related tissue damage and intolerance to dietary antigens, the study found. Researchers identified seven chromosome regions shared between the two diseases, suggesting a potential link in environmental triggers as well.

SourceUniversity of Cambridge·JournalNew England Journal of Medicine·DateDec 10, 2008

JCI online early table of contents: Dec. 6, 2007

Researchers have identified immunomodulatory anticancer drugs lenalidomide and pomalidomide as effective therapies for inducing fetal hemoglobin production in sickle-cell disease patients. Additionally, a new compound has been discovered to treat protein-losing enteropathy, a condition causing excessive protein loss from the gut.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 6, 2007

Oats not safe for all patients with celiac disease

A recent study published in PLoS Medicine found that oats can cause intolerance in some patients with celiac disease, triggering a similar molecular reaction as wheat, barley, or rye. This means that not all patients with celiac disease may be able to safely include oats in their diet.

SourcePLOS·JournalPLOS Medicine·DateOct 18, 2004

Understanding celiac disease

Researchers found that IL15 induces a series of biochemical changes in NKG2D signaling pathway converting CTL cells into Lymphokine-Activated Killer Cells. MICA molecules are present in elevated amounts in celiac patients' intestinal cells, providing a target for immune cell attacks

SourceCell Press·JournalImmunity·DateSep 14, 2004

Highlights of the November 2003 Journal of the American Dietetic Association

Researchers found that individuals with celiac disease often struggle to maintain a gluten-free diet outside the home, impacting lifestyle and quality of life. Supplement users, particularly women, face challenges in evaluating and selecting dietary supplements due to confusion over dosage directions, labeling, and claims.

SourceAmerican Dietetic Association·JournalJournal of the American Dietetic Association·DateNov 6, 2003

Discovery may lead to first medical treatment for Celiac disease

Researchers at Zengen discovered that synthetic alpha-Melanocyte-Stimulating Hormone (a-MSH) has an anti-inflammatory effect in celiac mucosa, which may control the inflammatory response and limit epithelial damage. This finding could lead to a medical treatment for Celiac disease, currently managed only with a strict gluten-free diet.

SourceZengen·JournalNeuroImmunoModulation·DateFeb 19, 2003

Nutritional Status In Newly Diagnosed Celiac Disease Patients Before And After The Institution Of A Celiac Disease Diet

A study of 40 newly diagnosed celiac disease patients found that those with total mucosal villous atrophy had lower erythrocyte folate and serum ferritin values, but no significant differences in nutritional status among other groups. After a gluten-free diet, most abnormal biochemical values normalized.

SourceAmerican Journal of Clinical Nutrition·JournalAmerican Journal of Clinical Nutrition·DateMar 27, 1998